期刊文献+

通过噬菌体筛选表达人CD59的CHO细胞结合的内化短肽 被引量:2

SCREENING THE SHORT INTERNATION PEPTIDE COMBINED WITH CHO CD59 THROUGH PHAGE
下载PDF
导出
摘要 目的筛选并鉴定与表达人CD59的中国仓鼠卵巢(CHO)细胞特异结合的内化短肽,为设计具有拮抗CD59肿瘤逃逸活性的短肽药物奠定基础。方法以高表达人CD59的CHO细胞为靶,对噬菌体随机十二肽库进行5轮亲和筛选,并进行竞争结合实验,用ELISA法筛选噬菌体阳性克隆并对其进行DNA序列分析。结果随机挑选的10个克隆中有6个与人CD59结合力高,测序后得到2个高度同源的氨基酸序列。结论获得了与高表达人CD59的CHO细胞结合的内化短肽序列,为进一步设计与肿瘤逃逸相关的CD59活性位点的短肽药物提供了参考依据。 Objective To search for a short internation peptide specifically combined with CHO cells for the purpose to establish a base of designing a peptide drug to inhibit CD59 on tumor sneaking through. Methods Taking CHO cells of high expressing CD59 as a target, a five-round affinity screening was done randomly for peptide library 12, After competitive test, positive phage clones were selected by ELISA and subsequently underwent DNA sequencing. Results Six out of 10 selected phage clones possessed the high affinity to CD59. After DNA sequencing, two pieces of short peptides highly homogeneous to CD59 were obtained. Conclusion This study might provide the reference for the design of a drug similar to the short peptide of CD59 on tumor sneaking through by obtaining the sequence of the internation peptide.
出处 《齐鲁医学杂志》 2006年第3期204-206,共3页 Medical Journal of Qilu
基金 国家自然科学基金资助项目(30170893)
关键词 卵巢细胞 肽库 内化短肽 CD59蛋白 膜蛋白质类 ovary cell peptide library internation peptide CD59 proteint membrane proteins
  • 相关文献

参考文献7

  • 1MARK J S,DALE I G,JOSEPH A T.A fresh look at tumor immunosurveillance and immunotherapy[J].Nature Immunology,2001,9(4):293-299.
  • 2GAVIN P D,LIOYD J O,ROBERT D S.The immunobiology of cancer immunosurveillance and immunoediting[J].Immunity,2004,21:137-148.
  • 3FISHEISON Z,DONIN N,ZELL S,et al.Obstacles to cancer immunotherapy:expression of membrane complement regulatory proteins (mCRPs) in tumors[J].Mol Immunol,2003,40(2/4):109-123.
  • 4DE N C,FONSATTI E,SIGALOTTI L,et al.Recombinant transmembrane CD59 (CD59-TM) confers complement resis-tance to GPI-anchored protein defective melanoma cells[J].J Cell Physiol,2002,190(2):200-206.
  • 5金冬雁译.分子克隆实验指南[M].第2版.北京:科学出版社,1995:5-57,870-898.
  • 6BABIKER A A,NILSSON B,RONQUIST G,et al.Transfer of functional prostasomal CD59 of metastatic prostatic cancer cell origin protects cells against complement attack[J].Prostate,2005,62(2):105-114.
  • 7高美华,王秋波,张艳丽,任书荣,王静.人突变CD59基因表达蛋白功能的研究[J].青岛大学医学院学报,2005,41(3):220-222. 被引量:4

二级参考文献7

  • 1Sims PJ, Faioni EM, Wiedmer T, et al. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity[J]. J Biol Chem, 1988,263:18205.
  • 2Acossta J, Halperin JA. Inhibition of the complement regulatory protein CD59 by non-enzymatic glycation:its potential pathogenic role in the proliferative complications of diabetes mellitus[J]. J Investig Med, 1996b,44:199A.
  • 3Bodian DL, Davis SJ, Morgan BP, et al. Mutational analysis of the active site and antibody epitopes of the complement inhibitory glycoprotein, CD59 [J]. J Exp Med,1997,185:507.
  • 4Halperin JA, Taratuska A, Rynkiewicz MA, et al. Transient changes in erythrocyte membrane permeability are induced by sublytic amounts of the complement membrane attack complex(C5b-9)[J]. Blood,1993,81 :200.
  • 5Brooimans RA. Relative roles of decay-accelerating factor, membrane cofactor prtotein, and CD59 in the protection of human endothelial cells against complement mediated lysis[J]. Eur J Immun,1992,22:3135.
  • 6金冬雁译. 分子克隆实验指南[M]. 第2版.北京:科学出版社,1995.870.
  • 7Ferriani VP. C5b-9 binds to N-termianl portion of CD59 [J]. Mol Immunol, 1993, 30(Suppl1):10.

共引文献3

同被引文献15

  • 1秦诚,蔡小勇.补体调节蛋白CD46、CD55及CD59在肿瘤免疫治疗中的研究进展[J].癌症,2006,25(11):1450-1453. 被引量:19
  • 2吴宁,高美华.人突变CD59基因在CHO细胞的表达、检测及生物活性研究[J].中国免疫学杂志,2007,23(5):456-459. 被引量:3
  • 3DONIN N, JURANZ K. Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid[J]. Clin Exp Immunol, 2003, 131(2):254- 263.
  • 4BJORGE L, HAKULINEN J. Ascitic complement system in ovarian cancer[J]. BrJ Cancer, 2005,92( 5):895-905.
  • 5BRADLEY S E, MARY K Z, ROBERT J B. Complement susceptibility in glutamine deprived breast cancer cells[J]. Cell Divisionm 2007,2:20.
  • 6ZHANG H F, EDNAN B. Targeting of functional antibody-Cd59 fusion proteins to a cell surface[J]. J Clin, 1999,103 (1) :55-61.
  • 7MURRAY K P,MATHURE S,KAUL R,et al.Expression of complement regulatory proteins-CD35,CD46,CD55 and CD59-in benign and malignant endometrial tissue[J].Gynecol Oncol,2000,76(2):176-182.
  • 8CHEN S,CARAGINE T,CHEUNG N K,et al.CD59 expressed on a tumor cell surface modulates decay-accelerating factor expression and enhances tumor growth in a rat model of human neuroblastoma[J].Cancer Res,2000,60(11):3013-3018.
  • 9SPILLER O B,CRIADO-GARCIAA O,RODRIAGUEZ D E,et al.Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack[J].Clin Exp Immunol,2000,121(2):234-241.
  • 10GUNZER M,JANICH S,VARGA G,et al.Dendritic cells and tumor immunity[J].Semin Immunol,2001,13(5):291-302.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部